GlassScriptPhysician profile
Alexander Sands
NPI 1700462322
$1,812.99
in general payments reported to CMS, 2019-2025
10 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $13.77 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $385.35 | 2025 | Accolade Sr |
| Abbott Laboratories | $380.46 | 2025 | Perclose Prostyle, Diamondback Coronary, Cardiomems |
| Bridgebio Pharma, INC. | $356.73 | 2025 | Attruby |
| Teleflex LLC | $307.91 | 2025 | Turnpike, Guideliner |
| Amgen INC. | $216.52 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $44.43 | 2025 | |
| Getinge USA Sales, LLC | $39.03 | 2025 | Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $31.82 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.98 | 2025 | |
| Esperion Therapeutics, INC. | $23.76 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Sands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.